Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Avadel Pharmaceuticals PLC
Inventory
Avadel Pharmaceuticals PLC
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
Inventory
$23.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
16%
|
|
|
Perrigo Company PLC
NYSE:PRGO
|
Inventory
$1.2B
|
CAGR 3-Years
4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
3%
|
|
|
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
|
Inventory
$483.1m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
40%
|
CAGR 10-Years
32%
|
|
|
Iterum Therapeutics PLC
NASDAQ:ITRM
|
Inventory
$1.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Cosmo Pharmaceuticals NV
SIX:COPN
|
Inventory
€13.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
15%
|
CAGR 10-Years
14%
|
|
|
Ovoca Bio PLC
LSE:OVB
|
Inventory
€0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Avadel Pharmaceuticals PLC
Glance View
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. The company is headquartered in Dublin, Dublin and currently employs 66 full-time employees. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.
See Also
What is Avadel Pharmaceuticals PLC's Inventory?
Inventory
23.9m
USD
Based on the financial report for Sep 30, 2025, Avadel Pharmaceuticals PLC's Inventory amounts to 23.9m USD.
What is Avadel Pharmaceuticals PLC's Inventory growth rate?
Inventory CAGR 10Y
16%
Over the last year, the Inventory growth was 49%.
